Open AccessPost-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
Author(s) -
Eran Zittan,
A. Hillary Steinhart,
Pavel Goldstein,
Raquel Milgrom,
Ian M. Gralnek,
Mark S. Silverberg
Publication year - 2021
Publication title -
clinical and translational gastroenterology
Language(s) - English
Resource type - Journals
ISSN - 2155-384X
DOI - 10.14309/ctg.0000000000000401
Subject(s) - adalimumab , medicine , calprotectin , gastroenterology , crohn's disease , confidence interval , area under the curve , prospective cohort study , faecal calprotectin , disease , inflammatory bowel disease